soul trial oral semaglutide cardiovascular outcomes 2024 results nejm and in... : New England Journal of Medicine The SOUL trial (Semaglutide Cardiovascular – SELECT Trial

and body composition in slightly overweight subjects

Western vendors who source from Chinese manufacturers (which many do) essentially perform the vetting process on your behalf and charge a markup for that service

Having more options available to patients is a good thing, says Daniel Drucker, an endocrinologist at the University of Toronto whose research paved the way for GLP-1 drugs but who was not involved in the new studies

For the IV regimen, a loading dose of 150 mg/kg in 200 cc is given for 15 minutes, followed by 50 mg/kg in 500 cc over 4 hours and then 100 mg/kg in 1000 cc over 16 hours.4,54,56,71 For the PO regimen, a loading dose of 140 mg/kg is given, followed by 70 mg/kg every 4 hours for a total of 18 total doses.54,56,71 Renal or hepatic dose adjustment is unnecessary

When focusing on increasing strength, evidence shows a focus on heavier weights with lower repetitions may be more beneficial

Some providers adjust titration speed based on body weight, metabolic markers, and side effect tolerance rather than sex alone